High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma

Table 2 Overview over relative expression of p53 isoforms in individual patients together with progression free-survival

Patient ID	Δ133p53ratio	p53βratio	p53γratio	Progression free- survival (months)
1	67.16	6.05	.86	29
2	19.17	4.90	0	0
3	187.50	17.35	0	0
4	19.87	0	0	14
5	0	0	0	7
6	17.21	0	0	1
7	42.31	17.08	27.85	3
8	234.46	0	0	14
9	22.37	0	2.63	10
10	5.16	.79	.57	5
11	9.47	6.35	0	58
12	7.93	1.68	.29	96
13	2.81	.27	.45	25
14	2.65	.67	.66	11
15	4.60	3.23	1.02	11
16	6.78	3.60	1.35	2
17	2.26	1.30	.74	0
18	5.75	2.10	.93	2
19	10.55	3.09	1.56	19
20	28.51	1.48	2.14	0
21	28.63	18.59	7.90	1
22	19.20	2.52	.54	31
23	35.80	18.67	5.20	15
24	33.33	2.89	.34	43
25	36.17	4.86	4.62	0
26	97.55	60.37	3.39	0
27	10.57	5.58	1.44	1
28	6.16	.98	.48	4
29	42.70	8.18	2.23	48
30	10.28	4.42	.61	28
31	60.74	0	0	11
32	38.58	5.87	2.71	0
33	10.13	2.66	2.23	0
34	85.68	0	0	11
35	7.51	0	1.94	15
36	25.74	7.85	1.64	6
37	32.86	13.85	6.09	0

ISSN: 1471-2407